全文获取类型
收费全文 | 6573篇 |
免费 | 409篇 |
国内免费 | 145篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 149篇 |
妇产科学 | 71篇 |
基础医学 | 302篇 |
口腔科学 | 33篇 |
临床医学 | 1060篇 |
内科学 | 921篇 |
皮肤病学 | 26篇 |
神经病学 | 255篇 |
特种医学 | 250篇 |
外国民族医学 | 5篇 |
外科学 | 905篇 |
综合类 | 992篇 |
现状与发展 | 2篇 |
预防医学 | 409篇 |
眼科学 | 31篇 |
药学 | 978篇 |
6篇 | |
中国医学 | 132篇 |
肿瘤学 | 589篇 |
出版年
2024年 | 9篇 |
2023年 | 64篇 |
2022年 | 108篇 |
2021年 | 171篇 |
2020年 | 163篇 |
2019年 | 157篇 |
2018年 | 145篇 |
2017年 | 151篇 |
2016年 | 174篇 |
2015年 | 204篇 |
2014年 | 416篇 |
2013年 | 432篇 |
2012年 | 430篇 |
2011年 | 440篇 |
2010年 | 383篇 |
2009年 | 344篇 |
2008年 | 324篇 |
2007年 | 297篇 |
2006年 | 306篇 |
2005年 | 275篇 |
2004年 | 231篇 |
2003年 | 176篇 |
2002年 | 165篇 |
2001年 | 147篇 |
2000年 | 137篇 |
1999年 | 108篇 |
1998年 | 96篇 |
1997年 | 86篇 |
1996年 | 78篇 |
1995年 | 86篇 |
1994年 | 67篇 |
1993年 | 64篇 |
1992年 | 66篇 |
1991年 | 62篇 |
1990年 | 46篇 |
1989年 | 48篇 |
1988年 | 43篇 |
1987年 | 38篇 |
1986年 | 44篇 |
1985年 | 59篇 |
1984年 | 51篇 |
1983年 | 22篇 |
1982年 | 42篇 |
1981年 | 28篇 |
1980年 | 26篇 |
1979年 | 31篇 |
1978年 | 24篇 |
1977年 | 13篇 |
1976年 | 14篇 |
1975年 | 10篇 |
排序方式: 共有7127条查询结果,搜索用时 0 毫秒
1.
目的探讨品管圈活动在喜疗妥联合新鲜马铃薯外敷治疗小儿输液外渗中的应用效果。方法选取我院2016年8月至2018年12月收治的输液外渗患儿100例,随机分为两组各50例。对照组给予50%硫酸镁湿敷治疗与常规护理,干预组采用喜疗妥联合新鲜马铃薯外敷,进行品管圈活动。对比两组的临床疗效、损伤痊愈时间和完全消肿时间。结果干预组的总有效率为90.00%,高于对照组的74.00%(P <0.05)。干预组的损伤痊愈时间和完全消肿时间短于对照组(P <0.05)。结论品管圈活动在喜疗妥联合新鲜马铃薯外敷治疗小儿输液外渗中的效果较好,可缩短临床症状消失时间,加快康复进程。 相似文献
2.
目的:探讨使用便携式微量输液泵在肿瘤化疗中持续输注氟尿嘧啶的应用效果。方法:选取我科2006年3月-2008年7月96例癌症化疗病人按入院先后顺序分为对照组和实验组,每组48例。对照组采用传统的化疗方式,采用浅静脉留置针直接从外周静脉输注氟尿嘧啶(5-Fu)连续5天,每天维持6-8小时。实验组采用浅静脉留置针连接便携式微量输液泵持续泵入氟尿嘧啶(5-Fu)120h~135h,两组均以21天为1个周期,观察两组病人化疗毒副反应发生情况。结果:实验组化疗毒副反应发生率明显低于对照组,平均住院时间明显缩短,两组比较差异有统计学意义(P〈0.01)。结论:使用便携式微量输液泵持续泵入氟尿嘧啶能减轻病人的毒副反应,缩短住院时间,提高肿瘤病人生活质量,有效减轻护士的工作负担。 相似文献
3.
Objective To investigate the best way to control the blood sugar level during the perioperation of bone fracture patients with type 2 diabetes(T2DM).Methods Bone fracture patients with T2DM were randomly divided into three groups:continuous subcutaneous insulin infusion group(insulin aspart,group CSII,n=20),glargine treatment group(insulin aspart+insulin glargine,group GA,n=20),and NPH treatment(insulin aspart+rh-insulin,group NA,n=20).The levels of fasting plasma glucose(FPG)and the 2 hours postprandial glucose(2h PG),blood glucose fluctuation(BGF),insulin dosage(ID),good effective time(GET),incidence of hypoglycemia,dawn phenomenon and infection,average time of stitches removal(ATSR),average hospitalized length(AHL)of three groups were compared.Results FPG and 2hPG,ID in group CSII[(6.32±1.18)mmol/L,(7.72±1.53)mmol/L,(35.40±1.60)IU]and group GA [(6.25±0.88)mmol/L,(7.32±1.17)mmol/L,(36.20±0.80)IU]were significantly lower than those of group NA [(7.44±1.36)mmol/L,(8.52±0.76)mmol/L,(40.50±2.40)IU,all P<0.05],simulaneously,BGF,GET incidence of complications,ATSR,AHL of group CSII and GA were significantly lower than those of group NA(all P<0.05).There were not significant difference between group CSII and group GA.Compared with group CSII,group GA had less costs in-hospital and better practicability.Conclusion Both CSII and insulin glargine combined with insulin aspart can effectively,safely,rapidly and stablely control hyperglycemia.and might be the first choice to control blood sugar for bone fracture patients with T2DM in perioperation. 相似文献
4.
Nishida Koyo Mihara Kiyoshi Takino Toichi Nakane Sachi Takakura Yoshinobu Hashida Mitsuru Sezaki Hitoshi 《Pharmaceutical research》1991,8(4):437-444
The effect of electric charge on the hepatic disposition of macromolecules was studied in the rat. Charged derivatives of dextran (T-70) and bovine serum albumin (BSA), mitomycin C–dextran conjugates (MMC-D), and lactosaminated BSA (Lac-BSA) were employed as model macromolecules. After intravenous injection, cationic macromolecules were rapidly eliminated from plasma because of their extensive hepatic uptake, while anionic and neutral macromolecules were slowly eliminated. Cationic macromolecules were recovered from parenchymal and nonparenchymal hepatic cells at a cellular uptake (per unit cell number) ratio of 1.4–3.2, while that of Lac-BSA was 14. During liver perfusion using a single-pass constant infusion mode, cationic macromolecules were continuously extracted by the liver, with extraction ratios at steady-state (E
ss) ranging between 0.03 and 0.54, whereas anionic and neutral macromolecules were almost completely recovered in the outflow at steady state. The E
ss for cationized BSA (Cat-BSA) and cationic MMC-Dcat were concentration dependent and decreased at low temperatures and in the presence of colchicine and cytochalasin B. The possible participation of the internalization process in the uptake of cationic macromolecules by hepatocytes was suggested. 相似文献
5.
6.
骨外科患者拔尿管时注入药物对排尿的影响 总被引:4,自引:0,他引:4
目的探讨提高长时间留置导尿管病人拔管后2h内排尿成功率的方法。方法按入院先后随机将64例导尿的男性骨折病人分两组,单数为观察组,双数为对照组。对照组常规拔尿管,观察组拔尿管时遵医嘱注入地塞米松5mg+2%利多卡因5ml+生理盐水5ml+庆大霉素8万U,比较首次排尿的自觉症状,包括尿痛、排尿困难、排尿障碍等。结果观察组较对照组病人首次排尿出现自觉症状的例数明显减少(P<0.01),有显著性差异。结论拔尿管时注入药物安全有效,明显提高了长期置管病人拔除尿管后首次排尿的成功率,减轻了病人的痛苦,有广泛的应用价值。 相似文献
7.
经动脉导管灌注垂体后叶素治疗10条犬小肠出血的实验研究结果表明,垂体后叶素灌注治疗的效果与出血部位累及的血管大小及出血速率有关。还提示垂体后叶素对较大血管引起的出血灌注治疗无效,其引起血管的收缩作用主要在末梢小血管。 相似文献
8.
9.
目的 探索早期乳腺癌保留乳房治疗的新途径。方法 1995 - 1997年采用术前动脉插管化疗加乳腺区段切除治疗Ⅰ、Ⅱ期乳腺癌共 2 6例 ,并随访 5年以上。结果 2 6例中 1例术后 2年 4个月死于肺转移 ,另 1例术后 4年死于其他疾病。 1例术后 1年复发 ,行全乳房切除后至今无瘤生存 6年。本组 3年生存率 (OS) 96 .15 % ,3年无瘤生存率 (DFS) 92 .3% ;5年OS 88.4 6 % ,5年DFS 88.4 6 %。结论 术前动脉插管化疗能提高肿瘤区域的药物浓度 ,杀灭部分癌细胞 ,减少术后复发。该疗法对部分Ⅰ、Ⅱ期乳腺癌病例是可行的。 相似文献
10.
Ming Li Allison Martin Cheng Wen Steven W. Turner Lynley K. Lewis Judith A. Whitworth 《Clinical and experimental pharmacology & physiology》1995,22(12):919-923
1. We tested the ability of ouabain to cause chronic hyper tension by continuously infusing ouabain for 28 days (mini-osmotic pump implantation; i.p.). The blood pressure and metabolic effects of sham (150 mmol/L NaCI; n= 12) or ouabain infusion (10 μg/kg per day; n= 14; 100 μg/kg per day; n = 14) were examined in conscious Sprague-Dawley rats. 2. Plasma ouabain concentrations measured after 28 days of ouabain infusion were as follows: sham, not detectable (n= 11); ouabain 10 μg/kg per day, 0.60 ± 0.07 nmol/L (n= 14); and ouabain 100 μg/kg per day, 7.17 ± 0.57 nmol/L (n= 14; P < 0.001). 3. Sham or ouabain infusion did not alter food intake, bodyweight, water intake or urine output in conscious rats. 4. Blood pressure was not altered by sham treatment. Ouabain at 10 μg/kg per day or 100 μg/kg per day did not produce consistent rises in blood pressure. Ouabain at 10 μg/kg per day increased blood pressure on treatment day 12 only (+ 6mmHg; P < 0.05), while at 100μg/kg per day blood pres sure increased on treatment days 16 (+ 9 mmHg; P < 0.05) and day 18 (+ 8mmHg; P < 0.05) only. There was no significant difference in blood pressure between sham and ouabain groups. 5. Renal blood flow was decreased in rats infused with ouabain at 10 μg/kg per day (2.0 ± 0.3 mL/min per 100 g body-weight; n= 5; P < 0.01) and 100 μg/kg per day (2.2 ± 0.4 mL/ min per 100 g bodyweight; n= 7; P < 0.05) compared with sham treatment (3.5 ± 0.2 mL/min per 100 g bodyweight; n= 6). Renal vascular resistance was increased in rats treated with ouabain at 10 μg/kg per day (65.5 ± 12.6 mmHg/mL per min per 100 g bodyweight; n= 5; P < 0.01) and 100 μg/kg per day (66.0 ± 15.6 mmHg/mL per min per 100 g bodyweight; n= 7; P < 0.05) compared with sham treatment (32.6 ± 2.5 mmHg/mL per min per 100 g bodyweight; n= 6). 6. High plasma concentrations of ouabain do not cause consistent increases in blood pressure in conscious Sprague-Dawley rats. 相似文献